Related Experiment Video
Updated: Jul 13, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Clinical Profiles and One-Year Outcome in Middle Eastern Patients With Atrial Fibrillation and Hypertension: Analysis
Abdullah Al-Kasasbeh1, Ahmad Abdalmajeed Alghzawi2,3, Mohamad Jarrah1
1Department of Internal Medicine, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.
Insights
Hypertension significantly worsens outcomes for atrial fibrillation patients in the Middle East. Patients with both conditions experienced higher rates of stroke, heart attack, and major bleeding events over one year.
Area of Science:
- Cardiology
- Clinical Research
- Public Health
Background:
- Limited data exists on hypertension's impact on atrial fibrillation outcomes in the Middle East.
- Hypertension is a common comorbidity in patients with atrial fibrillation.
Purpose of the Study:
- To assess the effect of coexisting hypertension on clinical profiles.
- To evaluate the 1-year prognosis of Middle Eastern patients with atrial fibrillation and hypertension.
Main Methods:
- A multicenter, prospective cohort study involving 1849 non-valvular atrial fibrillation patients.
- Patients were followed for 1 year, with outcomes compared between those with and without hypertension.
- Data collected included clinical features, medication use, and adverse events.
Main Results:
- 76.4% of atrial fibrillation patients had hypertension, with higher rates of comorbidities like diabetes and coronary heart disease.
- Hypertension was associated with increased risks of stroke, systemic embolism, acute coronary syndrome, and major bleeding.
- Atrial fibrillation patients with hypertension showed significantly higher rates of stroke/systemic embolism (4.5%), ACS (2.4%), and rehospitalization (27.9%) at 1 year.
Conclusions:
- Coexisting hypertension is linked to a worse baseline clinical profile in Middle Eastern atrial fibrillation patients.
- Hypertension significantly increases the risk of adverse cardiovascular events and major bleeding in this population.
- These findings highlight the importance of managing hypertension in atrial fibrillation patients for improved prognosis.
Abstract:
Studies on the impact of hypertension (HTN) on the outcome of patients with atrial fibrillation (AF) in the Middle East are scarce. The aim of this contemporary multicenter study is to evaluate the effect of the coexisting HTN on the baseline clinical profiles and 1-year prognosis in a cohort of Middle Eastern patients with AF. Consecutive AF patients in 29 hospitals and cardiology clinics were enrolled in the Jordan AF study (May 2019-December 2020). Patients were prospectively followed up for 1 year, and the study had no influence on their treatment, which was at the discretion of the treating physician. We compared clinical features, use of medications, and 1-year prognosis in patients with AF/HTN compared with AF/no HTN. Among 1849 non-valvular AF patients, 76.4% had HTN, with higher prevalence of diabetes, dyslipidemia, coronary heart disease, stroke, and left ventricular hypertrophy in HTN patients. There was a higher thromboembolic and bleeding risk among HTN patients. At 1 year, HTN patients had significantly higher rates of stroke and systemic embolism (SSE) (4.5%), acute coronary syndrome (ACS) (2.4%), rehospitalization (27.9%), and major bleeding events (3.0%) compared with non-HTN patients. In this cohort, the coexistence of HTN was associated with worse baseline clinical profile and 1-year outcomes.
More Related Videos
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension II: Pathophysiology
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension I: Introduction
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Acute Coronary Syndrome III: Diagnostic Studies

